Study of the Ability of Phenacetin, Acetaminophen, and Aspirin to Induce Cytotoxicity, Mutation, and Morphological Transformation in C3H/10T1/2 Clone 8 Mouse Embryo Cells

Cancer Research

Volumn 49, Issue 4, 1989, Pages 1038-1044

  Patierno, Steven R ^a   Lehman, Norman L ^a   Henderson, Brian E ^a   Landolph, Joseph R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PARACETAMOL; PHENACETIN;

ANIMAL CELL; CELL CULTURE; CELL TRANSFORMATION; DRUG CYTOTOXICITY; EMBRYO; EMBRYO CELL; MOUSE; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL;

ACETAMINOPHEN; ANIMAL; ASPIRIN; BIOTRANSFORMATION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CLONE CELLS; HAMSTERS; MICE; MICE, INBRED C3H; MICROSOMES, LIVER; MUTAGENICITY TESTS; MUTAGENS; MUTATION; PHENACETIN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024509521     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Tennant, R. W., Margolin, B. H., Shelby, M. D., Zeiger, E., Haseman, J. K., Spalding, J., Caspary, W., Resnick, M., Stasiewicz, S., Anderson, B., and Minor, R. Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science (Wash. DC), 236:933-941, 1987.
2. Evaluation of carcinogenic risk of chemicals to man. Some pharmaceutical drugs. IARC Monogr., 24:135-161, 1980.
3. Tsung-Hsien, C., Yu-Chung, L., Kwang-Yung, L., Cheng-Hsien, S., and Yee-Ping, C. Cocarcinogenic action of aspirin on gastric tumors induced by N-nitroso-N-methylnitroguanidine in rats. J. Natl. Cancer Inst., 70:1067-1075, 1973.
4. Cohen, S. M., Zenser, T. U., Marasaki, G., Fukushima, S., Mattammal, M. B., Rapp, N. S., and Davis, B. B. Aspirin inhibition of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced lesions of the urinary bladder correlated with inhibition of metabolism by bladder prostaglandin endoperoxide synthetase. Cancer Res., 41:3355-3359, 1981.
5. Honn, K. V., Bockman, R. S., and Marnett, L. J. Prostaglandins and cancer a review of tumor initiation through tumor metastasis. Prostaglandins, 21: 833-864, 1981.
6. Hinson, J. A. Reactive metabolites of phenacetin and acetaminophen: a review. Environ. Health Perspect., 49:71-79, 1983.
7. Nakanishi, K., Kurata, Y., Oshima, M., Fukushima, S., and Ito, N. Carcinogenicity of phenacetin: long-term feeding study on B6C3F1 mice. Int. J. Cancer, 29:434-444, 1982.
8. Isaka, H., Yoshii, H., Otsuji, A., Koike, M., Nagai, T., Koura,. M., Sugiyasu, K and Kanabayashi, T. Tumors of Sprague-Dawley rats induced by long-term feeding of phenacetin. Gann, 70:29-36, 1979.
9. Johansson, S. Carcinogenicity of analgesics: long-term treatment of Sprague-Dawley rats with phenacetin, phenazone, caffeine, and paracetamol (acetaminophen). Int. J. Cancer, 27:521-529, 1981.
10. Johansson, S., Angervall, L., Bengtsson, U., and Wahlquist, L. Uroepithelial tumors of the renal pelvis associated with abuse of phenacetin-containing analgesics. Cancer (Phila.), 33:743-753, 1974.
11. Calder, I. C., Goss, D. E., Williams, P. J., Funder, C. C., Green, C. R., Ham, K. N., and Tange, J. D. Neoplasia in the rat induced by N-hydroxyphenacetin, a metabolite of phenacetin. Pathology, 8:1-6, 1976.
12. Dunkel, U. C., Zeiger, E., Brusick, D., McCoy, E., McGregor, D., Mortal-mans, K., Rosenkrantz, H. S., and Simmon, V. F. Reproducibility of microbial mutagenicity assays. II. Testing of carcinogens and noncarcinogens in Salmonella typhimurium and Escherichia coli. Environ. Mut., 7(suppl.): 1-248.1985.
13. DeFlora, S., Russo, P., Pala, M., Fassina, G., Zunino, A., Bennicelli, C., Zanacchi, P., Comoirano, A., and Parodi, S. Assay of phenacetin genotoxicity using in vitro and in vivo test systems. J. Toxicol. Environ. Health, 16:355-377.1985.
14. Camus, A., Friesen, M., Croisy, A., and Bartsch, H. Species-specific activation of phenacetin into bacterial mutagen by hamster liver enzymes and identification of N-hydroxyphenacetin O-glucuronide as a promutagen in the urine. Cancer Res., 42:3201-3209, 1982.
15. Glowinski, I. B. Sanderson, N. D., Hayashi, S., and Thorgeirsson, S. S. Metabolic activation and genotoxicity of N-hydroxy-2-acetylaminofluorene and N-hydroxyphenacetin derivatives in Reuber (H4-II-E) hepatoma cells. Cancer Res., 44:1098-1104, 1984.
16. Wirth, P. J., Dybing, E., Von Bahr, C., and Thorgeirsson, S. S. Mechanism of N-hydroxyacetylarylamine mutagenicity in the Salmonella test system: metabolic activation of N-hydroxyphenacetin by liver and kidney fractions from the rat, mouse, hamster, and man. Mol. Pharmacol., 18: 117-127, 1980.
17. Wirth, P. H., Alewood, P., Calder, I., and Thorgeirsson, S. S. Mutagenicity of N-hydroxyphenacetin and their respective deacetylated metabolites in nitroreductase deficient Salmonella TA98FR and TA100FR. Carcinogenesis (Lond.) 3:167-170, 1982.
18. Mulder, G. J., Kadlubar, F. F., Mays, J. B., and Hinson, J. A. Reaction of mutagenic phenacetin metabolites with glutathione and DNA: possible implications for toxicity. Mol. Pharmacol., 26:342-347, 1984.
19. Hinson, J. A. Biochemical toxicology of acetaminophen. Biochem. Toxicol., 2:103-129, 1980.
20. Flaks, A., and Flaks, F. Induction of liver cell tumors in IF mice by paracetamol. Carcinogenesis (Lond.), 4:363-368, 1983.
21. Hiraga, K., and Fujii, T. Carcinogenicity testing of acetaminophen in F344 rats. J. Cancer Res., 76:79-89, 1985.
22. Hagiwara, A., and Ward, J. M. The chronic hepatotoxic, tumor-promoting, and carcinogenic effects of acetaminophen in male B6C3Fi mice. Fund. Appl. Toxicol., 7: 376-386, 1986.
23. Milam, K. M., and Byard, J. L. Acetaminophen metabolism, cytotoxicity, and genotoxicity in rat primary hepatocyte cultures. Toxicol. Appl. Pharmacol., 79:342-347, 1985.
24. Dahlin, D. C., Miwa, G. T., Lu, A. Y. H., and Nelson, S. D. N-Acetyl-p-benzoquinoneimine: a cytochrome P-450 mediated oxidation product of acetaminophen. Proc. Natl. Acad. Sci. USA, 81:1327-1331, 1984.
25. Gillette, J. R., Nelson, S. D., Mulder, G. J., Jollow, D. J., Mitchell, J. R., Pohl, L. R., and Hinson, J. A. Formation of chemically reactive metabolites of phenacetin and acetaminophen. In: R. Snyder, D. V. Parke, J. J. Kocsis, C. G. Gibson, and C. M. Witmer (eds.), Biological Reactive Intermediates, Vol. 2, pp. 931-950. New York: Plenum, 1982.
26. Rosen, G. M., Singletary, U. V., Jr., Rauckman, E. J., and Killenberg, P. G. Acetaminophen hepatotoxicity: an alternative mechanism. Biochem. Pharmacol., 32:1701-1706, 1983.
27. Thelen, M., and Wendel, A. Drug-induced lipid peroxidation in mice. V. Ethane production and glutathione release in the isolated liver upon perfusion with acetaminophen. Biochem. Pharmacol., 32:1701-1706, 1983.
28. Dahlin, C., and Nelson, S. D. Synthesis, decomposition kinetics, and preliminary toxicological studies of pure N-acetyl-p-benzoquinoneimine, a proposed toxic metabolite of acetaminophen. J. Med. Chem., 25:805-895, 1982.
29. Reznikoff, C. A., Brankow, D. W., and Heidelberger, C. Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. Cancer Res., 33:3231-3238, 1973.
30. Reznikoff, C. A., Bertram, J. S., Brankow, D. W., and Heidelberger, C. Quantitative and qualitative studies of chemical transformation of cloned C3H mouse cells sensitive to postconfluence inhibition of cell division. Cancer Res., 33:3239-3249, 1973.
31. Landolph, J. R., and Heidelberger, C. Chemical carcinogens produce mutations to ouabain resistance in transformable C3H/10TVi G 8 mouse embryo fibroblasts. Proc. Natl. Acad. Sci. USA, 76:930-934, 1979.
32. Landolph, J. R. Chemical transformation in C3H/10T'A G 8 mouse embryo cells: historical background, assessment of the transformation assay, and evolution and optimization of the transformation assay protocol. In: T. Kakanaga and H. Yamasaki (eds.), Transformation Assay of Established Cell Lines: Mechanism and Application, pp. 185-198. Lyon: International Agency for Cancer Research, 1985.
33. Barile, M. F. Mycoplasma infections of cell cultures. Isr. J. Med. Sci., 17: 555-562, 1981.
34. Landolph, J. R., Telfer, N., and Heidelberger, C. Further evidence that ouabain-resistant variants induced by chemical carcinogens in transformable C3H/{fl’/i G 8 mouse fibroblasts are mutants. MutaL Res., 72: 295-310, 1980.
35. Landolph, J. R., and Jones, P. A. Mutagenicity of 5-azacytidine and related nucleosides in C3H/10TY2 clone 8 and V79 cells. Cancer Res., 42:817-823, 1982.
36. Landolph, J. R., and Fournier, R. E. K. Microcell-mediated transfer of carcinogen-induced ouabain resistance from C3H/10TV2 G 8 mouse fibroblasts to human cells. Mutat. Res., 107:447-463, 1983.
37. Landolph, J. R. Mechanisms of chemically induced multistep neoplastic transformation in C3H/10TY2 cells. In: E. Huberman and S. H. Barr (eds.), Carcinogenesis, Vol. 10, pp. 211-223. New York: Raven Press, 1985.
38. Billings, P. C., Heidelberger, C., and Landolph, J. R. S-9 metabolic activation enhances aflatoxin-mediated transformation of C3H/10TY2 cells. Toxicol. Appl. Pharmacol., 77: 58-65, 1985.
39. Nesnow, S., Garland, H., and Curtis, G. Improved transformation of C3H/ IOTY2 cells by direct- and indirect-acting carcinogens. Carcinogenesis (Lond.), 3:377-380, 1980.
40. MacPherson, I. Soft agar techniques. In: P. F. Krue, Jr., and M. K. Petterson, Jr. (eds.), Tissue Culture: Methods and Applications, pp. 226-283. New York; Academic Press, 1973.
41. Boreiko, C., and Heidelberger, C. Isolation of mutants temperature-sensitive for expression of the transformed state from chemically transformed C3H/ IOTV2 cells. Carcinogenesis (Lond.), 1:1059-1073, 1980.
42. Mondal, S., Brankow, D. M., and Heidelberger, C. Two-stage chemical carcinogenesis in cultures of C3H/10TV2 cells. Cancer Res., 36:2254-2260, 1976.
43. Kohli, U., Sherma, S. K., Azarwal, S. S., and Sahib, M. K. Influence of nutritional status on acetaminophen metabolism in man. Indian J. Med. Res., 75:265-273, 1982.
44. Benedict, W. F., Banerjee, A., Gardner, A., and Jones, P. Induction of morphological transformation in mouse C3H/10TY2 clone 8 cells and chromosome damage in hamster A(Ti) Cl-3 cells by cancer chemotherapeutic agents. Cancer Res., 37:2202-2208, 1977.
45. Oglesby, L. A., Cudak, C., Curtis, G., Garland, H., Hyatt, B., Montgomery, L., and Nesnow, S. Relationship of N-arylacetamide metabolism and macromolecular binding to oncogenic transformation of C3H10TY2 G 8 cells. Cancer Lett., 16:231-237, 1982.
46. Mason, R. P., and Fisher, V. Free radicals of acetaminophen: their subsequent reactions and toxicological significance. Fed. Proc., 45:2453-2499, 1986.
47. Dybing, E., Holme, J. A., Gordon, W. P., Soderlund, E. J., Dahlin, D. C., and Nelson, S. D. Genotoxicity studies with paracetamol. MutaL Res., 138: 21-32, 1984.
48. Ross, R. K., Paganini-Hill, A., Landolph, J., Gerkins, V., and Henderson, B. E. Analgesics, cigarette smoking, and other risk factors for cancer of the renal pelvis and ureter. Cancer Res., 49:1045-1048, 1989.
49. Potter, D. W., Miller, A. W., and Hinson, J. A. Identification of acetaminophen polymerization products catalyzed by horseradish peroxidase. J. Biol. Chem., 260:12174-12180, 1985.
50. Laskin, D. L., and Pilaro, A. M. Potential role of activated macrophages in acetaminophen hepatotoxicity. I. Isolation and characterization of activated macrophages from rat liver. Toxicol. Appl. Pharmacol., 86:204-215, 1986.
51. Laskin, D. L., Pilar, A. M., and Ji, S. Potential role of activated macrophages in acetaminophen hepatoxicity. II. Mechanism of macrophage accumulation and activation. Toxicol. Appl. Pharmacol., 86:216-266, 1986.